Cambridge Investment Research Advisors, Inc. Alaunos Therapeutics, Inc. Transaction History

Cambridge Investment Research Advisors, Inc.

  • $29.9 Billion
  • Q4 2024

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 13, 2022
BUY
$0.41 - $1.24 $5,852 - $17,701
14,275 New
14,275 $17,000
Q4 2020

Feb 04, 2021
SELL
$2.09 - $3.09 $24,396 - $36,069
-11,673 Closed
0 $0
Q3 2020

Oct 29, 2020
BUY
$2.39 - $3.43 $27,898 - $40,038
11,673 New
11,673 $29,000
Q3 2018

Nov 02, 2018
SELL
$2.26 - $3.27 $110,299 - $159,592
-48,805 Closed
0 $0
Q2 2018

Aug 10, 2018
SELL
$3.02 - $4.94 $4,327 - $7,079
-1,433 Reduced 2.85%
48,805 $0
Q1 2018

May 09, 2018
BUY
$3.46 - $5.14 $3,466 - $5,150
1,002 Added 2.04%
50,238 $0
Q4 2017

Feb 22, 2018
BUY
$4.0 - $6.54 $1,224 - $2,001
306 Added 0.63%
49,236 $0
Q3 2017

Nov 07, 2017
BUY
$4.99 - $6.57 $32,435 - $42,705
6,500 Added 15.32%
48,930 $300,000
Q2 2017

Aug 08, 2017
BUY
N/A
42,430
42,430 $264,000

About Alaunos Therapeutics, Inc.

TCRT Quotes by TradingView
  • Ticker TCRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,182,000
  • Market Cap $329M
  • Description
  • Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...
More about TCRT
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email